Study S002714

Open, Randomized, Unicenter Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04626323
Acronym: OBESE-DKD
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: UNKNOWN
Enrollment: 60
Start: 2021-05-25
Primary completion: 2024-12
Lead sponsor: Hospital Alemão Oswaldo Cruz
Conditions: Diabetes Mellitus, Type 2; Kidney Disease, Chronic; Kidney Injury
Interventions: PROCEDURE:Roux-en-Y gastric bypass; DRUG:Best medical treatment
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER:CAAE - 37013420500000070

Registered primary outcomes

Mean differenceGlomerular filtration rate (GFR) [At 12 and 36 months after randomization]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0028935	Obesity in CKD: A Promising Path Forward. Friedman AN, Clinical journal of the American Society of Nephrology : CJASN	2022	Randomized trial	PMID 36126996 DOI	cites ClinicalTrials.gov:NCT04626323